13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the eastern cooperative oncology group
Open Access
- 15 March 1991
- Vol. 67 (6) , 1484-1486
- https://doi.org/10.1002/1097-0142(19910315)67:6<1484::aid-cncr2820670603>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Use of differentiation inducing agents in the myelodysplastic syndrome and acute non‐lymphocytic leukemiaAmerican Journal of Hematology, 1988
- Intensive treatment of acute leukemia in adults 70 years of age and olderCancer, 1987
- The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemiaCancer, 1986
- Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observationsBlood, 1983
- Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells.Journal of Clinical Investigation, 1982
- Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acidBlood, 1981
- 13-CIS RETINOIC ACID AND ACNEThe Lancet, 1980
- Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.Proceedings of the National Academy of Sciences, 1980
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979